Frédéric Maxime Vaz

Clinical Biochemist in Inborn Errors of Metabolism and Head of the Core Facility Metabolomics, Amsterdam UMC

Frédéric Maxime Vaz obtained his Master’s degree in Chemistry, specializing in biochemistry, at the University of Utrecht in 1997. He conducted his PhD research at the Laboratory Genetic Metabolic Diseases in Amsterdam, focusing on carnitine biosynthesis.
During his postdoctoral studies, he expanded his research on carnitine biosynthesis and began investigating Barth syndrome, which sparked his interest in lipid metabolism, particularly cardiolipin. During this period, he also trained as a clinical biochemist specializing in inborn errors of metabolism and became an NVKC-certified instructor in 2012.

Currently, Dr. Vaz is part of the management team of the Laboratory Genetic Metabolic Diseases at Amsterdam UMC, where he oversees metabolite diagnostics for inborn errors of metabolism. As the head of the Core Facility Metabolomics, he leads the development of advanced lipidomics and metabolomics platforms, including the necessary bioinformatics.
His work focuses on discovering novel biomarkers for inborn errors of metabolism and applying these platforms for both diagnostic and research purposes, with the goal of advancing the understanding and management of metabolic diseases.